A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
The dopamine agonist cabergoline does not provide clear benefits for maintaining weight loss in obese individuals who have shed >5 percent of body weight during a very low-calorie diet, according to the results of the 2-year Prevention of Weight Regain (POWER) study.
Antibiotic therapy in preterm, very low birth weight (VLBW) infants within the first 14 postnatal days increases the risk of subsequent late-onset sepsis, necrotizing enterocolitis (NEC) or death, a recent study has shown.
Physician-guided discontinuation of dual antiplatelet therapy (DAPT) does not yield considerable adverse event risks after percutaneous coronary intervention with drug eluting stent implantation, reports a recent study. On the other hand, DAPT disruption due to noncompliance increases the risk of major adverse cardiovascular events (MACEs).
At the recent Malaysian Community Pharmacy Business Forum (MyCPBF), a discussion forum was held on the subject of “Transcending Primary Healthcare Services: The Future of Specialized Pharmacy Services and Pharmacy Specialization”.
Nonsteroidal anti-inflammatory drugs (NSAIDs) appear to increase the risk of major bleeding, stroke or systemic embolism, and hospitalization among patients with atrial fibrillation (AF), suggest the results of the RE-LY* trial. Moreover, there is no difference in the safety and efficacy of dabigatran etexilate (DE) 150 and 110 mg twice daily relative to warfarin.